torsemide has been researched along with Diabetic Nephropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afrin, R; Arumugam, S; Giridharan, VV; Harima, M; Karuppagounder, V; Miyashita, S; Pitchaimani, V; Sreedhar, R; Suzuki, K; Thandavarayan, RA; Watanabe, K | 1 |
| Anabitarte-Prieto, A; Companioni, O; García-Bello, MA; Nóvoa-Mogollón, FJ; Plaza-Toledano, C; Rodríguez-Esparragón, F; Rodríguez-Pérez, JC; Suárez-Ortega, S | 1 |
1 trial(s) available for torsemide and Diabetic Nephropathies
| Article | Year |
|---|---|
Anti-albuminuric effects of the angiotensin AT1 receptor blocker telmisartan in hypertensive patients.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Diabetic Nephropathies; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Male; Middle Aged; Prospective Studies; Sulfonamides; Telmisartan; Torsemide; Treatment Outcome | 2011 |
1 other study(ies) available for torsemide and Diabetic Nephropathies
| Article | Year |
|---|---|
Comparative evaluation of torasemide and furosemide on rats with streptozotocin-induced diabetic nephropathy.
Topics: Animals; Blood Glucose; Body Weight; Diabetic Nephropathies; Disease Models, Animal; Diuretics; Echocardiography; Furosemide; Heme Oxygenase-1; Kidney; Male; NADH, NADPH Oxidoreductases; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Streptozocin; Sulfonamides; Torsemide | 2014 |